聚醇向神经疾病中的MAP激酶信号通路:了解分子机制和治疗点
Fahadul Islam1, Sumon Roy2, Mehrukh Zehravi3
1Department of Pharmacy, Faculty of Allied Health Sciences, Daffodil International University, Dhaka, 1207, Bangladesh.
Molecular neurobiology
|November 3, 2023
概括
多可以通过向MAPK途径来帮助控制神经炎症. 这篇评论探讨了植物化合物如何减轻神经疾病,如阿尔茨海默氏症和帕金森症.
科学领域:
- 植物性多和它们在生物调节中的作用.
- 神经炎症及其与神经系统疾病的联系.
背景情况:
- 线素激活蛋白激酶 (MAPK) 信号传递是关键的促炎途径,与神经炎症有关.
- 神经炎症有助于神经疾病的发病,如阿尔茨海默病 (AD),帕金森病 (PD) 和中枢神经系统损伤.
- 氧化应激 (OS) 加剧神经退行性疾病,包括多发性硬化症 (MS),AD,中风和PD.
研究的目的:
- 综合审查MAPK途径在神经疾病中的作用.
- 评估多在调节MAPK信号传递中对神经疾病 (NDs) 管理的治疗潜力.
主要方法:
- 文献综述侧重于神经炎症中MAPK信号传递.
- 对研究聚醇对MAPK通路的影响的研究分析.
- 对神经疾病中多的临床研究的评估.
主要成果:
- 聚醇显示出减轻氧化应激和神经炎症的潜力.
- 通过聚醇调节MAPK信号,为复杂的神经疾病提供了一个有前途的治疗策略.
- 几种多化合物表现出有益的效果,并且正在针对神经疾病进行临床试验.
结论:
- 聚醇通过向包括MAPK在内的多个途径,对控制神经疾病具有显著的前景.
- 饮食中摄入多醇可能会降低对神经退行性疾病的易感性.
- 需要进一步的研究和临床试验,以充分利用多在神经治疗中的治疗潜力.
相关概念视频
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564
Protein Kinases and Phosphatases
13.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
The Blood-brain Barrier
47.4K
Overview
47.4K


